THROMBOPROPHYLAXIS
Clinical trials for THROMBOPROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new THROMBOPROPHYLAXIS trials appear
Sign up with your email to follow new studies for THROMBOPROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a simple pill stop deadly clots in cancer patients?
Prevention Not yet recruitingThis large trial aims to see if a daily pill called apixaban can prevent dangerous blood clots in people with advanced lung cancer who are receiving chemotherapy. About 1,456 patients will be randomly assigned to take either the real pill or a placebo (sugar pill) for six months …
Matched conditions: THROMBOPROPHYLAXIS
Phase: PHASE3 • Sponsor: University of Birmingham • Aim: Prevention
Last updated Mar 31, 2026 12:12 UTC
-
ICU blood thinner mystery: why standard doses fail kidney patients?
Knowledge-focused Not yet recruitingThis study aims to understand how a common blood thinner (enoxaparin) works in critically ill patients with kidney failure, including those on dialysis. Researchers will measure blood levels of the drug in 60 ICU patients to see if current dosing guidelines are effective. The goa…
Matched conditions: THROMBOPROPHYLAXIS
Phase: NA • Sponsor: Clinique Saint Pierre Ottignies • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC